Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Helius Therapeutics

Request full access

Designed a state-of-the-art facility in Auckland with controlled growing systems, integrated extraction site, advanced cannabinoid research laboratories and manufacturing operations

Auckland, New ZealandFounded 2017Biotech & Life Sciences

About Helius Therapeutics

Helius Therapeutics is a pioneering biotechnology company focused on the research, development, and production of next-generation cannabinoid medicines. Operating primarily in New Zealand, Helius Therapeutics serves healthcare professionals and patients seeking effective medicinal cannabis solutions. The company integrates cutting-edge medical research with innovative product development to create safe and efficacious cannabis-based medicines. Helius Therapeutics generates revenue through the sale of its verified medicinal cannabis products, which meet the Ministry of Health's quality standards. The business model includes providing comprehensive resources for healthcare professionals, such as prescriber resources, product information sheets, clinical summaries, and therapeutic treatment areas. By leveraging its expertise in natural cannabis compounds and novel delivery systems, Helius aims to improve the quality of life for its clients.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2017
Headquarters
Auckland, New Zealand
Employees
17
Open positions
None listed
Dealroom signal
59.4/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Cannabis, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Jun 2026 $0 — Ora Pharm ↗
EARLY VC✓Equity / VC Jan 2021 $9.7M $39M Undisclosed ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Helius Therapeutics website traffic

Latest recorded traffic for Helius Therapeutics is 4.3K monthly website visits, down 32.8% over the last three months. Helius Therapeutics's team declined 52.8% over the past year.

Latest monthly visits4.3K 3-month web change-32.8% 1-year team growth-52.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Helius Therapeutics in the Auckland ecosystem

Live from Dealroom

The Helius Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Other known investors2 additional known investors

  • Ora Pharm
  • Guy Haddleton
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇳🇿 New Zealand100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Helius Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Helius Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.